The 38,200-molecular weight (unreduced)/41,900-molecular-weight (reduced) glycoprotein of bovine rotavirus, isolate C486, was identified as the major neutralizing antigen. This glycoprotein as well as the corresponding glycoprotein of another bovine rotavirus serotype also specifically attached to cell monolayers under normal conditions for virus adsorption in vitro. Further support for this glycoprotein being directly responsible for virus attachment to cells was that (i) infectious virus of both serotypes could compete with the C486 glycoprotein for cell surface receptors, and (ii) neutralizing monospecific antiserum and neutralizing monoclonal antibodies directed toward the glycoprotein could block this virus-cell interaction. Preliminary epitope mapping of the glycoprotein with monoclonal antibodies further localized the neutralization-adsorption domain to a peptide with an approximate molecular weight of 14,000. The effect of two protein modifications, glycosylation and disulfide bridging, on the reactivity of this peptide with antibodies and cell surface receptors was investigated. It was demonstrated that, whereas glycosylation did not appear to affect these reactivities, disulfide bridging seemed to be essential.
Rotaviruses cause important gastrointestinal disorders in animals and humans; however, to date no effective vaccine has been produced. Several approaches have been used for virus vaccine production with recent emphasis on synthetic oligopeptide and recombinant vaccines (1, 19) . Vaccines of these types are inherently safer and more stable than the conventional modified live vaccines, However, before such approaches are feasible for a rotavirus vaccine a thorough understanding of the protective antigens is required.
The proteins of infectious rotaviruses exist in a doubleshelled arrangement (16) . The two outer shell proteins are of particular interest since they play a critical role in important biological properties exhibited by the virus. Specifically, the minor outer shell protein (unreduced/reduced, 82,000 molecular weight [82K]/84K) is responsible for protease-enhanced infectivity (12, 17) and demonstrates hemagglutinating ability (17) . The other, more abundant protein (38.2K/41.9K) has been identified as the major neutralizing antigen for U.K. calf, rhesus monkey, and simian rotaviruses (7, 11, 13, 22) . Preliminary characterization of this protein identified Nglycosidically linked carbohydrate moieties that appear to stabilize the virus particle (23, 25) . In addition, a study of several simian (SAl) (11) and bovine (isolate C486) (24) rotavirus plaque isolates demonstrated heterogeneity in this glycoprotein.
This manuscript presents data on the identification and characterization of the major bovine rotavirus-neutralizing antigen of strain C486. Specific experiments were carried out to elucidate the functional role of this protein in the virion and a possible mechanism by which monoclonal antibodymediated neutralization occurs. A further attempt was made to characterize a biologically functional domain located on this glycoprotein and investigate the extent to which it was conserved between two different bovine rotavirus serotypes. * Corresponding author.
MATERIALS AND METHODS

Virus and cells. Bovine rotavirus isolates C486 and 2352
were cultured from the feces of diarrheic calves by a method described previously (2) . This isolate was propagated in African monkey kidney cells (MA-104) in the presence of 10 jig of trypsin (Difco Laboratories, Detroit, Mich.) per ml (2j.
MA-104 cells were propagated in Eagle minimal essential media (MEM) supplemented with 10% fetal bovine serum (GIBCO Laboratories, Grand Island, N.Y.). To culture virus, confluent MA-104 cells were washed once with MEM and then maintained in the absence of fetal bovine serum for the duration of the infection. Radiolabeling of virus. The procedure for radiolabeling proteins was to infect cells with virus and then replace the virus inoculum with methionine-free MEM. After a 3-h incubation at 370C, 25 24 h postinfection. After removal of cellular debris by low-speed centrifugation, virus was concentrated by pelleting through a 40% sucrose cushion containing i0 mM CaC12. The resulting pellet was then layered onto 11.5 ml of CsCl solution (analytical grade, density 1 .3688 g/ml; Sigma Chemical Co., St. Louis, Mo.) containing 1 mM CaC12 and centrifuged at 38,000 rpm in an SW41 rotor (Beckman model L5-65) for 17 h at 15°C. The complete double-shelled particle banded at a density of 1 .3692 g/ml.
Fractionation of virus proteins was accomplished by suspending purified virus in Laemmli sample buffer (20) and then electrophoresing in a polyacrylamide slab gel system (20) . When After adsorption, cell monolayers were washed with cold saline and processed. For identification of adsorbed proteins, 100 p.1 of Laemmli sample buffer containing 1% ,-mercaptoethanol was added per well, and the proteins were fractionated on polyacrylamide slab gels. To determine the amount of radioactivity adsorbed to cells, 1 ml of 1% Triton X-100 was added and then transferred to scintillation vials containing 10 ml of aqueous counting solution (Amersham).
Purification of virus outer capsid polypeptides. Doubleshelled virus particles were purified as described above. To purify the outer capsid polypeptides, the double-shelled virus-containing band from a CsCl gradient was first dialyzed overnight against 100 mM Tris-hydrochloride (plH 7.4). After dialysis, the virus was treated with 10 mM EDTA for 30 min at 37°C and then layered onto a preformed 20 to 45% (wt/wt) CsCl gradient and centrifuged at 35,000 rpm for 4 h at 10°C in an SW50.1 rotor. The top 250-,ul fraction of the gradient consistently contained the outer capsid polypeptides.
Peptide mapping (Cleveland digest). The protocol for peptide mapping of individual rotavirus polypeptides was described previously (25) . After localizing and excising individual 35S-labeled polypeptides from a 10% preparative gel, the gel slipes were processed by the procedure of Cleveland et al. (8) . The protein in each gel slice was then digested with various enzymes and by chemical cleavage by using cyanogen bromide'(Sigma), and the digests were electrophoresed through a 5% polyacrylamide stacking gel-15% resolving gel system. The resulting Cleveland intraperitoneally with an equal volume of incomplete Freund adjuvant. The mice were finally boosted by a tail vein injection with the appropriate virus preparation. Three days later the mice were sacrificed, and the spleens were removed for fusions.
(ii) Fusion of spleen cells with NS-1 cells. The procedure followed for fusion of spleen cells with NS-1 cells was essentially that of Greenberg et al. (13) . After the fusion, wells with visible colonies were tested by enzyme-linked immunosorbent assay (ELISA) against whole virus and individual polypeptides. Selected hybridomas were subcloned by limiting dilution with a macrophage feeder layer and grown to yield a 2-to 5-ml suspension. To ELISA procedure. The ELISA was carried out by following a previously described procedure (27) . Briefly, 96-well microtiter plates (Immulon 2; Dynatech Laboratories Inc., Alexandria, Va.) were incubated at 4°C overnight with an excess of protein (0.50 ,ug per well). If the antigen was in the form of individual polypeptides, the diluent was 1Ox carbonate-bicarbonate buffer (pH 9.6). When complete undisrupted virus particles were used as a substrate, the diluent was lx carbonate-bicarbonate buffer (pH 9.6 The procedure for reacting monoclonal antibodies or rabbit antisera with polypeptides transferred to nitrocellulose was essentially the same as that described by Braun et al. (6) . Each 11-by 1.0-cm nitrocellulose strip was incubated with 3 ml of phosphate-buffered saline containing 3% bovine serum albumin (fraction V, Sigma) and either 5 ,ul of horseradish peroxidase-coupled goat anti-rabbit IgG or horseradish peroxidase-coupled rabbit anti-mouse IgG. Subsequent development of the strips with 0.02% ortho-dianisidine dihydrochloride substrate proceeded for 18 h at room temperature.
RESULTS
Identification of the major neutralizing antigen of bovine rotavirus isolate C486. To identify the major neutralizing antigen of bovine rotavirus (isolate C486), monospecific antisera were produced against the two outer shell proteins (ca. 82K/84K and 38.2K/41.9K) and to the major inner shell protein (ca. 45K). Rabbits were immunized with individual proteins both in their reduced (84K, 41.9K) and unreduced (82K, 38.2K) forms (1:1) as described above. The monospecificity of the antisera was tested via ELISA and immunoblot ELISA with whole virus and the reduced and unreduced forms of the antigens (Table 1 and Fig. 1 ).
Serum neutralization tests were carried out with monospecific antisera raised against the three major rotavirus proteins. Four of the monoclonal antibodies and monospecific antisera against the 38.2K/41.9K protein neutralized virus most effectively (Table 1) . Antiserum to the 82K/84K protein also neutralized virus infectivity, but at a much lower dilution. These results are in agreement with previous studies designating the rotavirus major outer shell glycoprotein as the major neutralizing antigen.
Selection of virus-neutralizing monoclonal antibodies specific for the major glycoprotein. Monoclonal antibodies to the rotavirus proteins and in particular to the major glycoprotein were produced using two immunization regimes, as outlined above. Regardless of whether mice were immunized with a whole virus preparation or a purified outer capsid preparation, the percentage of reactive polyclonal antibodies was almost identical (data not shown). However, the percentage of polyclonal antibodies that were predominantly reactive to the glycoprotein as compared with the other viral proteins (i.e., gave the highest ELISA reading against the purified glycoprotein) was greater when hybridomas producing monoclonal antibodies were derived from mice immunized with a purified, outer shell preparation. Since the 45K inner shell protein is the most abundant in the virus, it was not suprising to find that many of the monoclonal antibodies derived from mice immunized with a whole virus preparation are predom- the whole virus polypeptide profile, even in the presence of 1% f-mercaptoethanol (data not shown).
Mechanism of bovine rotavirus neutralization mediated by antibodies to the major 41.9K glycoprotein. The specific mechanism whereby polyclonal and monoclonal antibodies to the major glycoprotein neutralize bovine rotavirus infectivity was elucidated by determining the function of this protein in the virus particle. The outer shell location of this protein suggested that it might be involved in the attachment to cells in vitro.
Only the major glycoprotein adhered to cells when a radiolabeled infected cell lysate was reacted with a cell monolayer under conditions normally employed for virus adsorption in vitro (Fig. 2) . Two observations made from this experiment are of particular interest. First, it is noteworthy that after adsorption of the lysate and before washing the cell monolayers, it appeared that only virus-specified proteins adhered to the monolayer. Subsequent washes, however, removed all of the viral proteins except for the major glycoprotein, as demonstrated by the lack of diminution in intensity after the first saline wash (Fig. 2) . Second, despite the fact that adsorption samples for gel analysis were prepared in 1% P3-mercaptoethanol, it appears that the unreduced subpopulation of this glycoprotein, which migrates at 38.2K, preferentially adsorbed to cell monolayers (Fig. 2) .
Further support implicating the major glycoprotein as the cell attachment protein of the virus was the ability of infectious C486 virus to prevent binding of this glycoprotein to cells in a competitive manner (Fig. 3) the N-linked carbohydrate moieties in this function was examined. Tunicamycin treatment of bovine rotavirus-infected cells was used to generate the unglycosylated counterpart of the 38.2K glycoprotein. When the unglycosylated (33.1K) protein was reacted with monospecific antiserum to the 38.2K/41.9K protein and monoclonal antibodies from hybridoma 11D12-6, a reaction comparable to that with the glycosylated (38.2K) protein was observed (Fig. 4) . Since both the polyclonal and monoclonal antibodies neutralize virus infectivity and block virus attachment to cells in vitro, their indifference to the presence of carbohydrate moieties on the 38.2K protein suggests that glycosylation is not necessary to the reactivity of this protein with these neutralizing antibodies. Furthermore, the unglycosylated and unreduced protein adsorbs to cells in vitro as efficiently as its (Fig. 5) , implying that glycosylation is not necessary for virus attachment to cells.
Effect of secondary structure, specified by disulfide bridging, on the reactivity of the bovine rotavirus major glycoprotein. A comparison of the ,3-mercaptoethanol-treated infected cell protein profile with the corresponding untreated profile demonstrates a shift in the mobility of the major glycoprotein from 38.2K (unreduced) to 41.9K (reduced). The appearance of a doublet, identified as a and b in the unreduced position and c and d in the reduced position (Fig.  5) , is likely due to the presence of two C486 rotavirus subpopulations, which demonstrate genetic heterogeneity with respect to this glycoprotein (Fig. 6) . The residual band (Fig. 5 , band e) in both the 5 and 15% P-mercaptoethanoltreated samples is either a cellular contaminant or a ,-mercaptoethanol-resistant subpopulation of the glycoprotein. However, since band e does not react with the antirotavirus serum, the former explanation is the most likely.
Contrary to the positive reactions of both the reduced and unreduced forms of the major glycoprotein with monospecific anti-38.2K/41.9K serum and antirotavirus serum, only the unreduced protein appeared capable of reacting with monoclonal antibodies derived from hybridomas 4B5-5, 11D10-4, 11D12-6, and 10D2-7 (Fig. 7, Table 1 ). Since these monoclonal antibodies specifically neutralized virus infectivity by blocking adsorption (Table 2) , one can infer that disulfide bridging is necessary for maintaining the in vitro reactivity of the major glycoprotein with these antibodies and also with cell surface receptors. In fact, adsorption experiments employing radiolabeled, infected cell lysates demonstrated that only the unreduced form of the glycoprotein remained attached to cells after several washes of the monolayer (Fig. 2) . tralization function of the major bovine rotavirus glycoprotein. Specifically, preparations of the glycoprotein were digested with various enzymes or chemically cleaved with cyanogen bromide. The resulting digests were electrophoresed and transferred to nitrocellulose paper. The reaction of these blotted digests with monoclonal antibodies indicated that, regardless of the enzyme or method employed, the smallest immune reactive peptide was ca. 14K (Fig. 8) The requirememt of disulfide bridges for maintaining the immune reactivity (antigenicity) of the 14K peptide was illustrated by the fact that 15% 1-mercaptoethanol treatment eliminated its ability to react with 11D12-6 monoclonal antibodies (Fig. 8, chymotrypsin panel, lane designated 3-ME).
Conservation of adsorption-neutralization domain between two bovine rotavirus serotypes. To further investigate whether the cellular receptor that mediates virus adsorption is the same regardless of the serotype of the virus, competition between a radiolabeled isolate 2352 (serotype 3)-infected cell lysate and infectious isolate C486 (serotype 1) virus particles was studied. Figure 9 illustrates that the corresponding major glycoprotein of isolate 2352 preferentially attaches to cells and can effectively compete with C486 virus particles for cellular receptors.
Evidence for the conservation of the adsorption-neutralization domain among at least two bovine rotavirus serotypes was provided by the fact that the major glycoprotein of isolate 2352 reacted with both anti-C486 38.2K/41.9K serum and with monoclonal antibodies (hybridoma 11D12-6) specific for the C486 38.2K major glycoprotein (Fig. 10) . In addition, monoclonal antibodies from hybridoma 11D12-6 also neutralized isolate 2352 infectivity as efficiently as isolate C486 infectivity ( 
DISCUSSION
Identification of the 38.2K/41.9K bovine rotavirus glycoprotein as the major neutralizing antigen is in agreement with reports of the analogous glycoprotein in various rotavirus isolates eliciting significant neutralizing activity against the homologous virus (7, 11, 13, 22) . The neutralizing ability of monospecific antiserum to the minor outer shell protein (92K/84K) was not surprising considering this protein's location on the virion and its role in infectivity (13, 17) . However, it is interesting that antiserum to the major inner shell protein (45K) also exhibits a low degree of neutralizing activity. Several (26) . Unequivocal support for this possibility awaits the identification of monoclonal antibodies that react withboth proteins.
Since the 38.2K/41.9K neutralizing antigen is an abundant outer shell protein responsible for virus attachment to cells in vitro, it is plausible that one mechanism of virus neutralization involves coating of the virus particle with sufficient monospecific polyclonal antibodies to prevent any virus-cell interaction. Another, more precise mechanism was demonstrated by employing monoclonal antibodies whose action was specifically directed to the adsorption-neutralization domain of this protein, thereby blocking virus attachment to cells. Two possibilities exist for the site of monoclonal antibody attachment. Viral adsorption to cells may be blocked by direct binding of these antibodies at or near the putative receptor binding site, or antibodies may bind some distance away from this site, thereby inducing a conformational change that alters the receptor-binding region (14, 15) . The fact that conditions that alter the adsorption ability of the protein also affect its antigenic reactivity with these monoclonal antibodies suggests that the antibodies are binding at or near the adsorption-neutralization domain.
Identification of a biologically functional domain was important for two reasons. First, such a domain is likely to be conserved among different rotavirus serotypes, as was (Fig. 4) . The almost universal modification of virus-neutralizing antigens by the addition of carbohydrate side chains has provoked numerous hypotheses that sugar residues are important to antigenicity, immunogenicity, secondary structure, and stability of the particular protein and consequently of the virus particle (18, 21) . For rotaviruses, there is preliminary evidence that virus stability in vitro may be determined by the presence of carbohydrate moieties on the major outer shell protein (23, 25) . However, to date, not enough information has been accumulated to assign any one of the above characteristics as being exclusively specified by sugar residues. It is possible that carbohydrate residues may assume different roles in different virus systems.
The inability of neutralizing monoclonal antibodies to recognize the 14K peptide as well as its parent protein in the reduced form indicates that secondary structure, as specified by disulfide bridges, is necessary for maintaining the antigenicity of the adsorption-neutralization domain. This supports the work of Bastardo et al. (3) , which demonstrated that antisera to the reduced outer shell proteins of the virus did not neutralize virus infectivity, whereas antisera produced against the unreduced form of the glycoprotein contained type-specific neutralizing antibodies.
Protein conformation also appears to be necessary for maintaining the reactivity of the major glycoprotein with cell surface receptors. Attachment of only the unreduced form of the glycoprotein to cell monolayers suggests that disulfide bridging must occur shortly after translation, since this appears to be the predominant protein form in infected cell lysate profiles. This observation is supported by the close association of the disulfide interchange enzyme with the rough endoplasmic reticulum (4) and by biochemical and ultrastructural studies demonstrating the involvement of this organelle in the morphogenesis of rotaviruses (23, 25 
